The field of “salivary diagnostics” includes studies utilizing samples obtained from a variety of sources within the oral cavity. These samples include; whole unstimulated saliva, stimulated whole saliva, duct saliva collected directly from the parotid, submandibular/sublingual glands or minor salivary glands, swabs of the buccal mucosa, tongue or tonsils, and gingival crevicular fluid. Many publications state “we collected saliva from subjects” without fully describing the process or source of the oral fluid. Factors that need to be documented in any study include the time of day of the collection, the method used to stimulate and collect the fluid, and how much fluid is being collected and for how long. The handling of the oral fluid during and post-collection is also critical and may include addition of protease or nuclease inhibitors, centrifugation, and cold or frozen storage prior to assay. In an effort to create a standard protocol for determining a biomarker’s origin we carried out a pilot study collecting oral fluid from 5 different sites in the mouth and monitoring the concentrations of pro- and anti-inflammatory cytokines detected using MesoScaleDiscovery (MSD) electrochemiluminesence assays. Our data suggested that 3 of the cytokines are primarily derived from the submandibular gland, while 7 of the cytokines come from a source other than the major salivary glands such as the minor salivary glands or cells in the oral mucosae. Here we review the literature on monitoring biomarkers in oral samples and stress the need for determining the blood/saliva ratio when a quantitative determination is needed and suggest that the term oral diagnostic be used if the source of an analyte in the oral cavity is unknown.
A rapid test for an infectious disease that can be used at point-of-care at a physician’s office, a pharmacy, or in the field is critical for the prompt and appropriate therapeutic intervention. Ultimately by treating infections early on will decrease transmission of the pathogen. In contrast to metabolic diseases or cancer where multiple biomarkers are required, infectious disease targets (e.g. antigen, antibody, nucleic acid) are simple and specific for the pathogen causing the disease. Our laboratory has focused on three major infectious disease; HIV, Tuberculosis, and Malaria. These diseases are pandemic in much of the world thus putting natives, tourists and military personnel at risk for becoming infected, and upon returning to the U.S., transmitting these diseases to their contacts. Our devices are designed to detect antigens, antibodies or nucleic acids in blood or saliva samples in less than 30 minutes. An overview describing the current status of each of the three diagnostic platforms is presented. These microfluidic point-of-care devices will be relatively inexpensive, disposable, and user friendly.
Utilizing saliva instead of blood for diagnosis of both local and systemic health is a rapidly emerging field. Recognition of oral-systemic interrelationships for many diseases has fostered collaborations between medicine and dentistry, and many of these collaborations rely on salivary diagnostics. The oral cavity is easily accessed and contains most of the analytes present in blood. Saliva and mucosal transudate are generally utilized for oral diagnostics, but gingival crevicular fluid, buccal swabs, dental plaque and volatiles may also be useful depending on the analyte being studied. Examples of point-of-care devices capable of detecting HIV, TB, and Malaria targets are being developed and discussed in this overview.
Oral samples, including saliva, offer an attractive alternative to serum or urine for diagnostic testing. This is particularly
true for point-of-use detection systems. The various types of oral samples that have been reported in the literature are
presented here along with the wide variety of analytes that have been measured in saliva and other oral samples. The
paper focuses on utilizing point-detection of infectious disease agents, and presents work from our group on a rapid test
for multiple bacterial and viral pathogens by monitoring a series of targets. It is thus possible in a single oral sample to
identify multiple pathogens based on specific antigens, nucleic acids, and host antibodies to those pathogens. The value
of such a technology for detecting agents of bioterrorism at remote sites is discussed.
Proceedings Volume Editor (1)
This will count as one of your downloads.
You will have access to both the presentation and article (if available).
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.